Estrogen is involved in promoting lung cancer cell division and metastasis. MICA and MICB function as ligands for NKG2D, an important immunoreceptor expressed on natural killer (NK) cells. However, whether estrogen regulates MICA/ B expression and affects tumor immune escape remains unknown. In this study, we measured the mRNA levels of MICA, MICB and ADAM17in non-small cell lung cancer (NSCLC) cell lines treated with estrogen. Surface expression of MICA/B on LTEP-a2 and A549 was detected using flow cytometry. We demonstrate that both mRNA and secretory protein levels of MICA/B in lung adenocarcinoma cell lines were upregulated by estradiol. Estradiol enhanced the expression of ADAM17, which was associated with the secretion of MICA/B. This secretion of MICA/B downregulated the NKG2D receptor on the surface of NK92 cells and impaired the cytotoxic activity of NK cells. Estradiol enhanced the expression of ADAM17, which was associated with the secretion of MICA/B. Furthermore, a significant correlation between the concentration of estradiol and the expression of MICA was found in tumor tissues of NSCLC patients. Therefore, we conclude that estrogen can regulate the expression and secretion of MICA/B through ADAM17, which helps lung cancer cells escape NKG2D-mediated immune surveillance.
INTRODUCTION
Lung cancer is the leading cause of cancer death worldwide. 1 While most lung cancers develop as a result of smoking, 2 some do not. Women appear to have a higher risk of non-small cell lung cancer (NSCLC) than men among the non-smoking population. 3 The reason for this phenomenon is still unclear; however, some evidence has shown that estrogen and the estrogen signaling pathway play a critical role in the development and pathogenesis of lung cancer. 4 Estrogen receptors (ERa and ERb) are widely expressed in normal lung tissue and NSCLC tissue. [5] [6] [7] 17b-estradiol can activate p44/p42 mitogen activated protein kinase and increase the proliferation of NSCLC cells. 8, 9 Moreover, aromatase, an estrogen synthetase, is also detected in NSCLC tissues, and lower levels of aromatase are predictive of a greater chance of survival in women with NSCLC. 10 Our previous study indicated that ERb was highly expressed on the tumors of NSCLC patients and silencing the expression of ERb could inhibit the growth of NSCLC cells in vivo. 11 However, the role estrogen plays in the development of lung cancers, especially in the immune surveillance of tumors, is still unclear.
As ligands for NKG2D, MICA and MICB are essential immunoreceptors expressed on natural killer (NK) cells. The interaction between NKG2D and its ligands plays an important role in immune surveillance. 12 MICA and MICB are widely expressed on cancer cells, and the engagement of MICA and MICB by NKG2D triggers the antitumor responses of NK cells,
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1 T cells and cd T cells. 13 Clinical data have demonstrated a high level of secretory MICA and MICB in the serum of cancer patients. 14, 15 Cancer cells can evade NKG2D-mediated immunity by the shedding of MICA and MICB, which results in impaired NKG2D function on NK cells and CTLs. 16, 17 Previous reports have suggested that estradiol may regulate MICA expression in human endometrial cells. 18 Therefore, we put forward a hypothesis that estrogen may regulate MICA/B expression and affect immune surveillance during the development of lung cancer.
MATERIAL AND METHODS
Cell culture and treatment A549 andLTEP-a2 cells were obtained from the Cell Bank of the Chinese Academy of Sciences (Shanghai, China). NK-92 cells (a gift from Zhigang Tian, University of Science and Technology of China, China) were maintained in a-MEM (Hyclone, Logan, Utah, USA) containing 100 U/ml IL-2 (Peptech, Burlington, MA, USA). The cells were maintained at 37 uC in a watersaturated atmosphere with 5% CO 2 .As described previously, 19 the cells were placed in phenol red-free media supplemented with 5% dextran-coated and charcoal-stripped fetal bovine serum for 72-96 h. EtOH was used as control for all experiments. The cells were treated with various concentrations of estradiol. For the indicated experiments, the cells were pretreated with 1 mM tamoxifen for 6 h before estradiol treatment.
Clinical samples
The tumor tissues were collected from 61 NSCLC patients during surgery at the Nanjing Chest Hospital (Nanjing, China). The pathological data of these 61 patients with NSCLC are summarized in Table 1 . The sera collected from61-patientswerekept at 280 uC before the assay. All of the patients consent to the study, and the protocol was approved by the institutional ethics committee of the Medical School of Nanjing University.
RNA isolation and quantitative real-time PCR analysis
Total RNA was isolated using the Trizol reagent (Invitrogen, Carlsbad, CA, USA) according to manufacturer's recommendations. One microgram total RNA was reverse-transcribed to synthesize cDNA according to manufacturer's protocols. Quantitative PCR analysis was carried out to quantify the mRNA levels of MICA, MICB and ADAM17, and expression of these candidate genes was normalized against the internal control b-actin of the same sample. The primer sequences of MICA, MICB, ADAM17 and b-actin are shown in Table 2 . For mRNA quantification, the relative expression of these genes was obtained using the 2 2DDCt method. Western blot analysis LTEP-a2 and A549 cells were lysed in an ice-cold buffer (150 mM NaCl, 0.02% NaN 3 , 0.1% SDS, 50 mM TrisCl, pH 8.0, 100 mg/ml 
Estrogen upregulates MICA/B expression through ADAM17 J Ren et al phenylmethylsufonyl fluoride, 1 mg/ml Aprotinin, 1% Triton) for 30 min. The cells lysates were collected, and the concentrations were measured using the BCA Protein Assay Reagent Kit (Beyotime, Shanghai, China). Fifty micrograms of lysate were then separated by 12% SDS-PAGE gel and transferred onto PVDF membranes (Roche, Penzberg, Upper Bavaria, Germany). After blocking in TBST-containing 2% BSA for 1 h, antibodies specific for ADAM17 (1 : 500; Santa Cruz, Dallas, Texas, USA), GAPDH (1 : 2000; Cell Signaling Technology, Inc., Danvers, MA, USA) and HRP-conjugated goat anti-rabbit secondary antibodies (1 : 1000; Promab, Richmond, CA , USA ) were used. The protein bands were detected by the enhanced chemiluminescence reaction (Kibbutz Beit Haemek, D.N. Oshrat, Israel), and the intensity of each band was quantified by Quantity One software.
Small interfering RNAs transfection targeting ADAM17
Approximately 3310 6 cells/well were cultured in 12-well plates and transfected with either ADAM17-siRNA (100 nM) or negative control siRNA (100 nM) using Lipofectamine 2000 (Invitrogen), according to the manufacturer's instructions. The specific RNAi sequence for human ADAM17 was synthesized by RiboBio (Co Ltd, Guangzhou, China). Forty-eight hours after transfection, the cells were collected and treated with estrogen. The cells and supernatants were harvested at appropriate times with estrogen for flow analysis, quantitative real-time PCR and ELISA.
NK cell cytotoxicity assay Two million CD56-selected NK effector cells were isolated from the peripheral blood of a healthy donor. Primary NK cells and NK92 cells were treated with estradiol with and without MICA/B neutralizing antibodies at 37 uC for 24 h. K562 cells were labeled using 5.0 mM CFSE for 8 min at 37 uC. The NK cytotoxicity assay used an NK cells/K562 cells ratio of 5 : 1 and was incubated for 4 h at 37 uC in 5% CO 2 .
Statistical analysis
All of the results are presented as the means6s.e.m. of at least three independent experiments. The Student's t-test was used to assess differences between two groups. A value of P,0.05 was considered statistically significant.
RESULTS

The transcription of MICA and MICB is upregulated by estradiol
To determine whether estradiol regulates the transcription of MICA and MICB in NSCLC cells, A549 and LTEP-a2 cells were exposed to physiologically relevant estradiol concentrations (5310 28 M) for 4 h and 10 h. MICA and MICB mRNA expression was significantly upregulated by estradiol in both cell lines (Figure 1a and b) . This increase in MICA and MICB mRNA was only observed at the concentration of 5310 28 M estradiol, while 5310 27 M and 5310 26 M estradiol had no effect on the expression of MICA/B (Figure 1c) . We also determined the MICA genotype in these cell lines. Both MICA*001 and MICB*008 were detected in A549 cells and LTEP-a2 cells (Supplementary  Figure 1a) . To determine whether the estradiol-induced increase of MICA and MICB was mediated directly by estrogen receptors, small interfering RNAs targeting ERa and ERb were designed and validated (Supplementary Figure 1b) . As shown in Figure 1d and e, both ERa and ERb were involved in the activation of MICA/B. We also pre-treated LTEP-a2 cells with tamoxifen for 6 h before estradiol treatment. As shown in Figure 1f , tamoxifen could block the estradiol-induced increase in MICA mRNA expression, while it had no effect on MICB expression (data not shown).
The secretory protein of MICA is promoted by estradiol Previous research has shown that MICA and MICB proteins can exist in two forms: surface protein and secretory protein. 20 In our study, after treatment of estradiol (5310 28 M), surface proteins of MICA/B were transiently increased and returned to normal levels after 48 h (Figure 2a and b) . We then detected the secretory protein of MICA and MICB using ELISA. While LTEP-a2 and A549 cells produced significant amounts of MICA secretory protein (Figure 2c ), MICB secretory protein was not detected in the supernatants (data not shown).
Estradiol increases the expression of ADAM17
Previous studies have shown that ADAMs (including ADAM10 and ADAM17) and MMPs were the main proteases mediating the secretion of MICA and MICB. 21, 22 Therefore, we investigated the effect of estradiol on the expression of ADAM10, ADAM17, MMP9 and MMP14. The mRNA expression of ADAM17 was significantly increased after treatment with estradiol ( Figure 3a ). However, estradiol had no effect on the expression of ADAM10, MMP9 and MMP14 (Figure 3b-d) . The protein level of ADAM17 was also significantly increased after estradiol treatment (Figure 3e ). We also found that silencing ERa and ERb could downregulate ADAM17 expression (Figure 3f ).
ADAM17 is involved in the estradiol-induced increase of MICA/B
To verify whether ADAM17 was involved in the estradiolinduced increase of MICA/B, siRNA was used to knock down ADAM17 in LTEP-a2 cells (Figure 4a) . Interestingly, the mRNA levels of MICA decreased 56.4% and the expression of MICB decreased 62.8% in the siADAM171estradiol group compared with the estradiol group (Figure 4b and c) . The secretory protein level of MICA in LTEP-a2 cells was also significantly decreased after infection with siADAM17 (Figure 4d ).These data suggested that ADAM17 could regulate both the transcription and secretion of MICA/B.
Estradiol decreases NKG2D expression and NK cell cytotoxicity through the regulation of MICA/B Secretory MICA and MICB could bind to NKG2D on NK cells and downregulate the surface expression of NKG2D. [23] [24] [25] To Although estradiol alone showed little influence on CD107 expression, estradiol pre-treated supernatants could increase the levels of CD107 on the surface of NK-92 cells (Figure 5c and d).
The cytotoxicity of the NK92 cells cultured with the supernatants was further confirmed. As shown in Figure 5e , the cytotoxicity of NK92 cells pre-treated with estradiol was significantly decreased. In addition, MICA/B neutralizing antibodies reversed these inhibitory effects. Consistent with NK cell lines, primary NK cells also showed decreased cytotoxicity when pre-treated with estradiol (Figure 5f ).
Correlation between estradiol and MICA/B expression in NSCLC patients MICA and MICB expression levels in the tumor tissues from 61 NSCLC samples were detected to extend our analysis to clinical patients. No significant differences were found in MICA and MICB mRNA expression between females and males (Figure 6a and b). There was a significant correlation between the concentration of estradiol and the expression of MICA (r50.67, P50.0023) (Figure 6c ) in the female group; however, there was no correlation between estradiol and MICB expression (r50.28, P50.25). To further identify the correlation between estradiol and MICA/B, we performed immunohistochemical analysis on NSCLC samples and normal tissue. As shown in Figure 6d -f, the expression levels of aromatase and MICA/B in NSCLC tissue were much higher than those in normal tissue.
DISCUSSION
Estrogen and estrogen signaling pathways have been reported to induce epithelial-mesenchymal transition and play a critical role in the development and pathogenesis of lung cancer. 4 In this study, our data have important consequences for the role of estrogen in the immune surveillance of the tumor microenvironment. First, we found that both mRNA and secretory protein levels of MICA/B in lung adenocarcinoma cell lines were upregulated by estradiol. We further proved that the regulatory role of estradiol on MICA/B is mediated through the enhanced expression of ADAM17. This secretion of MICA/B downregulated the NKG2D receptor on the surface of NK92 cells, and impaired the cytotoxic activity of NK cells. In addition, we extended our findings to the clinical setting: there was a significant correlation between the concentration of estradiol and the expression of MICA in tumor tissues of NSCLC patients.
The protein forms of MICA/B, surface protein and shedding protein perform difference functions in the immune response. These molecules are absent from most cells and tissues, but can be induced by viral and bacterial infections and are frequently expressed in epithelial tumors. [26] [27] [28] [29] Surface MICA/B can lead to the activation of NK cells and cd T cells that help to eliminate the cancer cells, while the shedding of MICA and MICB can help cancer cells escape the cytotoxicity of NK cells and cd T cells. 20 In our study, we found that both mRNA and shedding protein levels of MICA/B in lung adenocarcinoma cell lines were upregulated by estradiol. However, estradiol has little effect on the surface protein of MICA/B. We also analyzed the effects of estrogen receptors on the estradiol-induced increase in MICA and MICB. We found that tamoxifen can block the estradiol-induced increase in MICA mRNA expression but has no effect on MICB expression. These differing effects of tamoxifen may be due to its interaction with the estrogen receptor. Tamoxifen could combine with the estrogen receptor to form a complex, which could upregulate the expression of ERBB2, 30 and ERBB2 signaling could increase the expression of MICB. 31 Given that MMPs and ADAMs are involved in the shedding of MICA and MICB, 21, 22 we investigated the effect of estradiol on the expression of ADAM10, ADAM17, MMP9 and MMP14 in lung cancer cells. Our data showed that only ADAM17 was significantly increased after estradiol treatment. Moreover, both mRNAs levels and shedding proteins of MICA/B in 0 C O N E s t r o g e n S u p e r n a t a n t E s t r o g e n + S u p e r n a t a n t S u p e r n a t a n t E s t r o g e n + S u p e r n a t a n t C O o n t r o l E s t r o g e n E s t r o g e n + a n t i -M I C A E s t r o g e n + a n t i -M ADAM17-siRNA-transfected cells were significantly decreased. Based on these data, we conclude that ADAM17 is a specific protein involved in the estradiol-induced increase in MICA/B. 17b-estradiol can suppress the cytotoxicity and proliferative capacity of murine splenic NK1.1 in vitro. 32 The interaction between NKG2DL and NKG2D plays an important role in immune surveillance, and MICA/B are ligands for NKG2D.
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To validate whether the increased shedding of MICA can also downregulate the expression of NKG2D, NK-92 cells were cocultured with tumor supernatants with or without estradiol pre-treatment. Our data indicated that estradiol pre-treated supernatants downregulated the expression of NKG2D on NK-92 cells. Moreover, CD107 is a sensitive marker of NK cell activity on NK-92 cells. 33 We found that the expression of CD107 on NK-92 cells was also increased when cocultured with tumor supernatants, but not when pre-treated with estradiol. It is reasonable to predict that treatment with estradiol could promote the expression and secretion of NKG2D. Thus, the secretion of MICA/B downregulated the NKG2D receptor on the surface of NK92 cells, thereby impairing the cytotoxicity of NK92 cells that is involved in immune surveillance.
Taken together, our observations have important consequences. Specifically, estradiol can regulate the expression and secretion of MICA/B through ADAM17, impair the cytotoxic activity of NK cells and eventually lead to the escape of tumor cells from NKG2D-mediated immune surveillance. 
